Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MADx Exosomes
- Development stage
- Preclinical
- Lead developer
- Aruna Bio
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Intravenous, Oral, Inhalation, Intranasal, Intratumoral, Intraarticular, Rectal, Buccal, Vaginal, Subcutaneous, Intracutaneous, Intraperitoneal, Intramuscular, Intrasynovial, Intrasternal, Intrathecal, Intralesional, Intracranial, Intramyocardial, Intraspinal
01
Overview
MADx Exosomes is an exosome-based therapeutic platform being developed by ArunA Biomedical for the treatment of central nervous system (CNS) disorders. These neural-derived exosomes are designed to leverage their natural ability to cross the blood-brain barrier (BBB) to deliver therapeutic payloads or provide intrinsic neuroprotective and regenerative signals to the brain. Currently in the discovery stage, the MADx program represents a component of ArunA's broader pipeline of extracellular vesicle-based treatments for neurological conditions. Specific molecular targets and the exact mechanism of action for this particular asset have not been disclosed, but the platform aims to address unmet needs in CNS therapeutic applications.
Beyond the preview
Go deeper on MADx Exosomes.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MADx Exosomes.